CENTRAL TRUST Co Sells 543 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

CENTRAL TRUST Co decreased its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Get Rating) by 1.1% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 50,666 shares of the pharmacy operator’s stock after selling 543 shares during the quarter. CENTRAL TRUST Co’s holdings in Walgreens Boots Alliance were worth $1,591,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently bought and sold shares of the company. Sage Private Wealth Group LLC bought a new stake in Walgreens Boots Alliance in the 3rd quarter worth approximately $25,000. EverSource Wealth Advisors LLC lifted its position in Walgreens Boots Alliance by 289.4% in the third quarter. EverSource Wealth Advisors LLC now owns 915 shares of the pharmacy operator’s stock valued at $29,000 after purchasing an additional 680 shares during the last quarter. Blume Capital Management Inc. lifted its position in Walgreens Boots Alliance by 35.7% in the third quarter. Blume Capital Management Inc. now owns 950 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 250 shares during the last quarter. Bank of New Hampshire lifted its position in Walgreens Boots Alliance by 56.4% in the third quarter. Bank of New Hampshire now owns 960 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 346 shares during the last quarter. Finally, Ronald Blue Trust Inc. bought a new stake in Walgreens Boots Alliance in the second quarter valued at approximately $46,000. Institutional investors own 56.71% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have weighed in on WBA. UBS Group boosted their price objective on Walgreens Boots Alliance to $40.00 in a research report on Monday, November 28th. Cowen upgraded Walgreens Boots Alliance from a “market perform” rating to an “outperform” rating and boosted their price objective for the company from $43.00 to $54.00 in a research report on Tuesday, November 22nd. Truist Financial lowered their price objective on Walgreens Boots Alliance from $44.00 to $42.00 and set a “hold” rating for the company in a research report on Thursday, January 19th. Loop Capital assumed coverage on Walgreens Boots Alliance in a report on Wednesday, February 22nd. They set a “buy” rating and a $45.00 target price for the company. Finally, Credit Suisse Group decreased their target price on Walgreens Boots Alliance from $42.00 to $41.00 and set a “neutral” rating for the company in a report on Friday, January 6th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $43.43.

Walgreens Boots Alliance Stock Up 0.8 %

NASDAQ:WBA opened at $33.54 on Thursday. The firm has a market cap of $28.93 billion, a P/E ratio of -9.75, a P/E/G ratio of 1.48 and a beta of 0.72. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.36 and a current ratio of 0.70. Walgreens Boots Alliance, Inc. has a fifty-two week low of $30.39 and a fifty-two week high of $48.62. The firm has a 50-day simple moving average of $35.97 and a two-hundred day simple moving average of $36.50.

Walgreens Boots Alliance (NASDAQ:WBA – Get Rating) last released its quarterly earnings data on Thursday, January 5th. The pharmacy operator reported $1.16 earnings per share for the quarter, beating analysts’ consensus estimates of $1.15 by $0.01. The business had revenue of $33.38 billion during the quarter, compared to analyst estimates of $33.04 billion. Walgreens Boots Alliance had a negative net margin of 2.24% and a positive return on equity of 13.57%. Walgreens Boots Alliance’s revenue was down 1.5% compared to the same quarter last year. During the same period last year, the business earned $1.68 EPS. Analysts predict that Walgreens Boots Alliance, Inc. will post 4.5 earnings per share for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, March 10th. Stockholders of record on Thursday, February 16th were paid a $0.48 dividend. The ex-dividend date was Wednesday, February 15th. This represents a $1.92 dividend on an annualized basis and a dividend yield of 5.72%. Walgreens Boots Alliance’s dividend payout ratio is presently -55.81%.

Walgreens Boots Alliance Company Profile

(Get Rating)

Walgreens Boots Alliance, Inc engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment.